All In Biotech

Drug Trial Radar · NCT01268215

Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.

The Effect of Endotracheal Instillation of Surfactant With and Without Budesonide on the Development of Bronchopulmonary Dysplasia in Ventilator-dependent, Extremely Low Birth Weight Infants: A Pilot Study

Last checked: Nov 20, 2026Latest source record: Dec 29, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

45

Planned (sponsor's estimate)

Start

Jul 2010

Primary completion

Jun 2012

Study completion Dec 2013

Sponsor

Lead sponsor
East Carolina UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Dec 29, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
All sexes, from 24 weeks, up to 28 weeks
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Pilot study to evaluate the safety and the efficacy of endotracheal instillation of pulmonary surfactant, with or without topical steroid (Budesonide), as a prophylactic treatment for Bronchopulmonary Dysplasia (a form of chronic lung disease) in extremely low birth weight infants. Cytokines (a group of inflammatory mediators) are measured in the tracheal aspirate before and after instillation of the study drugs.

Conditions

  • Bronchopulmonary Dysplasia

Interventions

  • InfasurfDrug

    Endotracheal instillation of Infasurf once per week for three weeks

  • PulmicortDrug

    Endotracheal instillation, once per week for three weeks

  • ShamOther

    None instilled through the endotracheal tube

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To measure the effect of surfactant with and without Budesonide on the development of BPD in ELBW infants.Time frame: Supplemental oxygen requirement at 36 weeks' postmenstrual age (PMA)

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • NICU-Pitt County Memorial Hospital

    Greenville, North Carolina · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.